These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35351268)
1. Recent clinical research on the application of liquid biopsy in neuroblastoma. Liu SY; Wen FQ Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):339-344. PubMed ID: 35351268 [TBL] [Abstract][Full Text] [Related]
2. Epitope detection in monocytes (EDIM) for liquid biopsy including identification of GD2 in childhood neuroblastoma-a pilot study. Stagno MJ; Schmidt A; Bochem J; Urla C; Handgretinger R; Cabanillas Stanchi KM; Saup R; Queudeville M; Fuchs J; Warmann SW; Schmid E Br J Cancer; 2022 Oct; 127(7):1324-1331. PubMed ID: 35864157 [TBL] [Abstract][Full Text] [Related]
3. Advances in liquid biopsy in neuroblastoma. Zhuo Z; Lin L; Miao L; Li M; He J Fundam Res; 2022 Nov; 2(6):903-917. PubMed ID: 38933377 [TBL] [Abstract][Full Text] [Related]
4. Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma. Su Y; Wang L; Jiang C; Yue Z; Fan H; Hong H; Duan C; Jin M; Zhang D; Qiu L; Cheng X; Xu Z; Ma X BMC Cancer; 2020 Feb; 20(1):102. PubMed ID: 32028911 [TBL] [Abstract][Full Text] [Related]
5. Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients. Van Roy N; Van Der Linden M; Menten B; Dheedene A; Vandeputte C; Van Dorpe J; Laureys G; Renard M; Sante T; Lammens T; De Wilde B; Speleman F; De Preter K Clin Cancer Res; 2017 Oct; 23(20):6305-6314. PubMed ID: 28710315 [No Abstract] [Full Text] [Related]
6. Progress toward liquid biopsies in pediatric solid tumors. Weiser DA; West-Szymanski DC; Fraint E; Weiner S; Rivas MA; Zhao CWT; He C; Applebaum MA Cancer Metastasis Rev; 2019 Dec; 38(4):553-571. PubMed ID: 31836951 [TBL] [Abstract][Full Text] [Related]
7. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review. Van Paemel R; Vlug R; De Preter K; Van Roy N; Speleman F; Willems L; Lammens T; Laureys G; Schleiermacher G; Tytgat GAM; Astrahantseff K; Deubzer H; De Wilde B Eur J Pediatr; 2020 Feb; 179(2):191-202. PubMed ID: 31897843 [TBL] [Abstract][Full Text] [Related]
8. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis. Marachelian A; Villablanca JG; Liu CW; Liu B; Goodarzian F; Lai HA; Shimada H; Tran HC; Parra JA; Gallego R; Bedrossian N; Young S; Czarnecki S; Kennedy R; Weiss BD; Goldsmith K; Granger M; Matthay KK; Groshen S; Asgharzadeh S; Sposto R; Seeger RC Clin Cancer Res; 2017 Sep; 23(18):5374-5383. PubMed ID: 28559462 [No Abstract] [Full Text] [Related]
9. Urine-Based Liquid Biopsy for Nonurological Cancers. Jain S; Lin SY; Song W; Su YH Genet Test Mol Biomarkers; 2019 Apr; 23(4):277-283. PubMed ID: 30986103 [TBL] [Abstract][Full Text] [Related]
10. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer. Zhang X; Ju S; Wang X; Cong H Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187 [TBL] [Abstract][Full Text] [Related]
11. Circulating tumor DNA in neuroblastoma. Wei M; Ye M; Dong K; Dong R Pediatr Blood Cancer; 2020 Oct; 67(10):e28311. PubMed ID: 32729220 [TBL] [Abstract][Full Text] [Related]
12. Level of Seven Neuroblastoma-Associated mRNAs Detected by Droplet Digital PCR Is Associated with Tumor Relapse/Regrowth of High-Risk Neuroblastoma Patients. Thwin KKM; Ishida T; Uemura S; Yamamoto N; Lin KS; Tamura A; Kozaki A; Saito A; Kishimoto K; Mori T; Hasegawa D; Kosaka Y; Nino N; Takafuji S; Iijima K; Nishimura N J Mol Diagn; 2020 Feb; 22(2):236-246. PubMed ID: 31837427 [TBL] [Abstract][Full Text] [Related]
13. Narrative review: precision medicine applications in neuroblastoma-current status and future prospects. Zhou J; Du H; Cai W Transl Pediatr; 2024 Jan; 13(1):164-177. PubMed ID: 38323175 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential. Galardi A; Colletti M; Businaro P; Quintarelli C; Locatelli F; Di Giannatale A Curr Med Chem; 2018 Feb; 25(5):584-600. PubMed ID: 28971761 [TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma in adolescents: the Italian experience. Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209 [TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma. Mohammadi M; Goodarzi M; Jaafari MR; Mirzaei HR; Mirzaei H Cancer Gene Ther; 2016 Nov; 23(11):371-372. PubMed ID: 27740613 [TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Ye Q; Ling S; Zheng S; Xu X Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometry as a diagnostic tool in neuroblastoma. Furlanetto G; Spagnol F; Alegretti AP; Farias MG; Soares VJ; Daudt LE; Loss JF; Scroferneker ML; Michalowski MB J Immunol Methods; 2021 Nov; 498():113135. PubMed ID: 34478717 [TBL] [Abstract][Full Text] [Related]
20. [N-myc gene copies in children with neuroblastoma and its clinical significance]. Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]